Evaluating Severe Hypertriglyceridemia: Differential Diagnosis and FCS Recognition

When a patient presents with triglycerides reliably above 1000 mg/dL, the differential spans common secondary drivers and a rare but consequential genetic syndrome, and distinguishing between them requires a structured approach.

Stephan P. Babirak, MD, PhD, approaches the evaluation from an endocrinologist's vantage point, beginning with the most prevalent cause. Insulin deficiency in type 1 diabetes impairs lipoprotein lipase synthesis, the rate-limiting step for clearing triglycerides from circulation. Type 2 diabetes, particularly in the setting of agents that suppress LPL or augment VLDL production, is an even more common driver. Hypothyroidism, Cushing's disease, pregnancy, and prediabetes can each push triglycerides into the severe range.

Babirak references work from his group in the 1990s showing that more than 90% of patients presenting with chylomicronemia either carry a diabetes diagnosis or will develop one over their lifetime. The rare autosomal recessive form caused by complete LPL absence he estimates at roughly 1 in 100,000 to 1 in 1,000,000.

Alan Brown, MD, MHA, describes his clinical checklist: normal renal function, no proteinuria, euthyroid state, no alcohol use, no active diabetes, and triglycerides that remain persistently elevated regardless of intervention. He adds that the response, or absence of response, to fibrates and omega-3 fatty acids is among the most diagnostically revealing findings. He recounts a patient from early in his career who threw a bottle of omega-3 supplements at him, insisting each dose triggered pancreatitis. Dietary fat in any form, including omega-3 fatty acids, can precipitate pancreatitis in true FCS because patients cannot clear chylomicrons.

Both experts emphasize the team approach FCS demands. Babirak describes the hazard of referring an FCS patient who has developed secondary diabetes to a dietitian unfamiliar with the syndrome: a moderate-fat, low-carbohydrate diabetic diet accelerates chylomicron accumulation and worsens the clinical picture. Brown adds that patients can develop both endocrine and exocrine pancreatic insufficiency over time, and that presentations in childhood are not uncommon, with dietary restrictions affecting the entire family's daily life.